RT @EricTopol: Genomics at Your Fingertips http://t.co/iehVcVfP by @drkevincampbell HT @cyphergenomics #CDoM
Via Brian Shields
Join Scoop.it for Free
Share ideas that matter on the social web and experience
the benefits of curating the world's best content.
I don't have a Facebook, a Twitter or a LinkedIn account
Already have an account: Login
SIGN UP
Attract your communities of interest by sharing ideas that matter
86
Live longer in good health and you will have a chance to extend your healthy life even further
Curated by
Ray and Terry's
Scoop.it Score
86
Visitors
Loading...
Updated
May 21
Created
Feb 9, 2012
Created by
Scoops
879
Reactions
2314
Edit Tag
Follow
|
Rescooped by Ray and Terry's from Biomarkers and Personalized Medicine onto Longevity science |
Scoop.it!
Via Brian Shields
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
No
Related Scoops
iRobot’s RP-Vita Telepresence Robots Start Work At Seven Hospitals |
FDA To Decide Whether Antibacterial Soap Is Safe – After Four Decades |
UK tries out new model for gene testing in cancer patients |
 Your new post is loading...
Scoop.it!
Why Do Homocysteine-Lowering B Vitamin and Antioxidant E Vitamin Supplementations Appear To Be Ineffective in the Prevention of Cardiovascular Diseases?
A review published in Cardiovascular Therapeutics examined recent reports of ineffective vitamin supplements. They found that some of the studies were poorly designed and inconclusive. There may have been complications due to subjects medications, as well.
The report concludes that vitamin use for cardiovascular disease cannot be scientifically rejected based solely on these studies. The authors believe that further research should be conducted to investigate the uses of vitamins for disease prevention. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
No
|
Interesting article on the possible future development of sequencing in the primary care office. The article builds off a new technology reported by Anne Eisenberg in a recent NY Times article. This technology from a company called Knome, allows a single Lab or office to sequence a person's genome. The technology costs about $125,000.